🌍·12h agodiscovery
Revolution Medicines Opens RASolute 305 Trial of Zoldonrasib in RAS G12D Pancreatic Cancer
Publisher
T
The Clinical Trial Vanguard
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- The Clinical Trial Vanguard
- Region
- Global
- Scope
- discovery
- Published
- June 24, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: The Clinical Trial Vanguard
Scope: discovery
Related coverage
More related coverage
Investing.com/4h ago
West Pharmaceutical Services stock hits 52-week high at $338.73
CoStar/4h ago
News | Pharmaceutical giant plans more than $1 billion expansion in Jacksonville, Florida
statnews.com/4h ago
At BIO, a glimpse behind Lilly and Chai’s partnership
GlobeNewswire/5h ago